Last reviewed · How we verify

NCT02521922: VSP

Vital Signs Patch Early Feasibility and Usability Study

Completed NA Last updated 4 April 2017
What this trial tests

NA trial testing VSP System - NEHB Configuration in Vital Signs in 72 participants. Completed in 1 April 2017.

Timeline
16 April 2014
Primary endpoint
9 June 2016
1 April 2017

Quick facts

Lead sponsorLifeWatch Services, Inc.
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposesupportive care
Enrollment72
Start date16 April 2014
Primary completion9 June 2016
Estimated completion1 April 2017
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

LifeWatch Services, Inc.

Who can join

18 and older, any sex, with Vital Signs. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To assess the feasibility and usability of the VSP System in the in-patient hospital setting to monitor vital signs using a patch, brain, gateway, and console. The VSP System will be incorporated into the study site's Information Technology infrastructure.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Vital Signs

Currently open trials in the same condition.

Other LifeWatch Services, Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02521922.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing